Literature DB >> 35307742

Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study.

Jason R Fangusaro1, Arzu Onar-Thomas2, Tina Young Poussaint3, Shengjie Wu2, Azra H Ligon4, Neal Ian Lindeman4, Anuradha Banerjee5, Roger Packer6, Lindsay B Kilburn6, Ian F Pollack7, Ibrahim A Qaddoumi2, Paul Graham Fisher8, Girish Dhall9, Patricia Ann Baxter10, Susan G Kreissman11,12, L Austin Doyle13, Malcolm A Smith13, Maryam Fouladi14, Ira J Dunkel15.   

Abstract

Entities:  

Year:  2022        PMID： 35307742      PMCID： PMC9340620          DOI： 10.1093/neuonc/noac029

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  2 in total

Review 1.  Neurosurgery for Optic Pathway Glioma: Optimizing Multidisciplinary Management.

Authors:  Derek C Samples; Jean M Mulcahy Levy; Todd C Hankinson
Journal:  Front Surg       Date:  2022-05-04

Review 2.  BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors.

Authors:  Dario Talloa; Silvia Triarico; Pierpaolo Agresti; Stefano Mastrangelo; Giorgio Attinà; Alberto Romano; Palma Maurizi; Antonio Ruggiero
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.